전신홍반루푸스에 동반된 항인지질항체 증후군 환자의 마취 및 수술 후 중환자 관리
Anesthetic and Postoperative Intensive Care for Patient with Systemic Lupus Erythematosis and Antiphospholipid Syndrome
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The antiphospholipid syndrome (APS) is characterized by vascular thrombosis despite of prolongation of coagulation profile in laboratory findings and pregnancy morbidity in the presence of antiphospholipid antibody. It occurs primarily or secondarily to autoimmune disease. This case report concerns a pelviscopic left ovarian cystectomy in a 32-year-old female with APS and systemic lupus erythematosis. To manage the hypercoagulability, oral warfarin and low molecular weight haparin were given pre- and postoperatively. In perioperative period, we monitored activated clotting time to prevent intraoperative thrombosis and tried to avoid dehydration, hypothermia and infection.
Abstract
The antiphospholipid syndrome (APS) is characterized by vascular thrombosis despite of prolongation of coagulation profile in laboratory findings and pregnancy morbidity in the presence of antiphospholipid antibody. It occurs primarily or secondarily to autoimmune disease. This case report concerns a pelviscopic left ovarian cystectomy in a 32-year-old female with APS and systemic lupus erythematosis. To manage the hypercoagulability, oral warfarin and low molecular weight haparin were given pre- and postoperatively. In perioperative period, we monitored activated clotting time to prevent intraoperative thrombosis and tried to avoid dehydration, hypothermia and infection.
참고문헌 (15)
- Madan R, "The anaesthetist and the antiphospholipid syndrome", Anaesthesia, 52, pp.72~76 (1997)
- Wilson WA, "International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop", Arthritis Rheum, 42, pp.1309~1311 (1999)
- Galli M, "Thrombocytopenia in the antiphospholipid syndrome", Br J Haematol, 93, pp.1~5 (1996)
- Triplett DA, "Antiphospholipid antibodies", Arch Pathol Lab Med, 126, pp.1424~1429 (2002)
- Escalante A, "Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus", Am J Med, 98, pp.559~565 (1995)
- Levine JS, "The antiphospholipid syndrome", N Engl J Med, 346, pp.752~763 (2002)
- Santoro SA, "Antiphospholipid antibodies and thrombotic predisposition:underlying pathogenetic mechanisms", Blood, 83, pp.2532~2540 (1994)
- Amigo MC, "Kidney disease in antiphospholipid syndrome", Rheum Dis Clin North Am, 32, pp.509~522 (2006)
- Bertsias GK, "EULAR recommendations for the management of Systemic Lupus Erytematosus (SLE) Report of a Task Force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)", Ann Rheum Dis (2007)
- Jafri SM, "Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy", Am Heart J, 147, pp.3~15 (2004)
- Narchi P, "Spinal anaesthesia and the use of anticoagulants", Best Pract Res Clin Anaesthesiol, 17, pp.443~449 (2003)
- Menon G, "Anaesthetic implications of the anti-cardiolipin antibody syndrome", Br J Anaesth, 70, pp.587~590 (1993)
- Lee JY, "Anesthetic management of a patient with antiphospholipid syndrome", Korean J Anesthesiol, 53, pp.266~269 (2007)
- Fahy BG, "Anesthesia with antiphospholipid antibodies:anesthetic management of a parturient with Lupus anticoagulant and anticardiolipin antibody", J Clin Anesth, 8, pp.49~53 (1996)
- Sander O, "Equivalence of hydroxyethyl starch HES 130", 0.4 and HES 200, Acta Anaesthesiol Scand, pp.2003, 47[DOI]